Fund Card

Fund Card

IDBI Healthcare Fund-Reg(G)

As on Jan-24-2020 change fund
10.91  up0.02 (0.18%)

fund objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2018-20192019-2020
NAV in Rs (as on 24-Jan-2020)10.0710.91
Net Assets(Rs Crores) (as on 24-Jan-2020) 35.99 31.32
Scheme Returns(%)(Absolute)0.708.23
B'mark Returns(%)(Absolute)7.46-1.69
Category Rank38/7323/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2019-2020-2.780.827.40NA
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...12.43 
Divis Laboratories Ltd.8.25 
Cipla Ltd.7.64 
Lupin Ltd.6.16 
Sanofi India Ltd.5.59 
Dr. Reddys Laboratories Ltd.5.51 
Ipca Laboratories Ltd.5.44 
Pfizer Ltd.4.05 
Aurobindo Pharma Ltd.3.94 
Natco Pharma Ltd.3.79 

Category

Sector Funds

Launch Date

28-Feb-19

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

31.32

portfolio price to book value

5.52

investing style?

Mid Growth

fund manager?

Uma Venkatraman

inception date (regular plan)

28-Feb-19

expense ratio (regular plan) %

2.72

Alpha [%]

0.01

Beta [%]

0.41

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs78.36
Hospital & Healthcare Services6.04
Miscellaneous2.80
Insurance2.16
Chemicals 1.86
Household & Personal Products1.10

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201931.32-0.463.517.91NANANANA9.10BUYSIP
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,416.99-0.093.698.562.925.793.9013.8819.22BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015166.080.094.817.138.773.39NANA-1.02BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005394.61-0.134.7210.894.570.790.0011.5016.25BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999926.47-0.024.9010.421.55-2.14-0.0813.3313.92BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018243.421.939.5713.8815.14NANANA14.98BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018366.91-0.015.7110.4910.38NANANA9.25BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20181,286.90-0.094.9611.249.10NANANA5.08BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019171.460.095.927.66NANANANA11.00BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974